JP2023107988A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023107988A5 JP2023107988A5 JP2023098521A JP2023098521A JP2023107988A5 JP 2023107988 A5 JP2023107988 A5 JP 2023107988A5 JP 2023098521 A JP2023098521 A JP 2023098521A JP 2023098521 A JP2023098521 A JP 2023098521A JP 2023107988 A5 JP2023107988 A5 JP 2023107988A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate according
- conjugate
- radionuclide
- formula
- divalent linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (10)
- 式
B-L-P
の接合体
(式中、Bは、式:
Lは、二価リンカーであり、
Pは、
前記二価リンカーLは、式:NH-(CH 2 ) 2 -NHのジラジカルを含まず、かつ、*NH[(CH 2 ) 2 O] n *、*NH[(CH 2 ) 2 O] n -(CH 2 ) 2 NH*、*NH[(CH 2 ) 2 O] n -(CH 2 ) 2 -C(O)*、*NH[(CH 2 ) 2 O] n -(CH 2 ) 2 -C(O)NH*、*NH[(CH 2 ) 2 O]n-(CH 2 ) 2 -C(O)NH-(CH 2 ) 2 *、又は、*NH[(CH 2 ) 2 O] n -(CH 2 ) 2 -C(O)NH-(CH 2 ) 2 NH*を含み、ここでnは1~約12の整数である)またはその薬学的に許容できる塩。 - 前記Pは、
- P-Lは、
- Pは、
- P-Lは、
- Pは、放射性核種をさらに含む、請求項1~5のいずれか1項に記載の接合体。
- 前記放射性核種は、陽電子放出放射性核種または放射線治療薬を含む、請求項6に記載の接合体。
- 前記陽電子放出放射性核種または前記放射線治療薬は、 66 Ga、 68 Ga、 18 F、 177 Lu、 90 Y、 64 Cu、 61 Cu、 89 Zr、 45 Ti、 51 Mn、 63 Zn、 82 Rb、 124 I、 11 C、 13 N、または、 15 Oである、請求項7に記載の接合体。
- 前記二価リンカーLは、*NH(CH 2 ) 2 O-(CH 2 ) 2 NH*、*NH[(CH 2 ) 2 O] 2 -(CH 2 ) 2 NH*、*NH[(CH 2 ) 2 O] 6 -(CH 2 ) 2 NH*、または、*NH[(CH 2 ) 2 O] 12 -(CH 2 ) 2 NH*を含む、請求項1に記載の接合体。
- 前記リンカーは、*NH[(CH 2 ) 2 O] 2 -(CH 2 ) 2 NH*を含む、請求項1に記載の接合体。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361904400P | 2013-11-14 | 2013-11-14 | |
US201361904387P | 2013-11-14 | 2013-11-14 | |
US61/904,400 | 2013-11-14 | ||
US61/904,387 | 2013-11-14 | ||
US201361909822P | 2013-11-27 | 2013-11-27 | |
US61/909,822 | 2013-11-27 | ||
JP2021175168A JP7299285B2 (ja) | 2013-11-14 | 2021-10-27 | 陽電子放出断層撮影用の化合物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021175168A Division JP7299285B2 (ja) | 2013-11-14 | 2021-10-27 | 陽電子放出断層撮影用の化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023107988A JP2023107988A (ja) | 2023-08-03 |
JP2023107988A5 true JP2023107988A5 (ja) | 2023-09-15 |
Family
ID=53058011
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016529948A Active JP6464166B2 (ja) | 2013-11-14 | 2014-11-13 | 陽電子放出断層撮影用の化合物 |
JP2018208786A Pending JP2019023232A (ja) | 2013-11-14 | 2018-11-06 | 陽電子放出断層撮影用の化合物 |
JP2020060644A Pending JP2020165975A (ja) | 2013-11-14 | 2020-03-30 | 陽電子放出断層撮影用の化合物 |
JP2021175168A Active JP7299285B2 (ja) | 2013-11-14 | 2021-10-27 | 陽電子放出断層撮影用の化合物 |
JP2023098521A Pending JP2023107988A (ja) | 2013-11-14 | 2023-06-15 | 陽電子放出断層撮影用の化合物 |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016529948A Active JP6464166B2 (ja) | 2013-11-14 | 2014-11-13 | 陽電子放出断層撮影用の化合物 |
JP2018208786A Pending JP2019023232A (ja) | 2013-11-14 | 2018-11-06 | 陽電子放出断層撮影用の化合物 |
JP2020060644A Pending JP2020165975A (ja) | 2013-11-14 | 2020-03-30 | 陽電子放出断層撮影用の化合物 |
JP2021175168A Active JP7299285B2 (ja) | 2013-11-14 | 2021-10-27 | 陽電子放出断層撮影用の化合物 |
Country Status (14)
Country | Link |
---|---|
US (3) | US20160287731A1 (ja) |
EP (3) | EP3069147A4 (ja) |
JP (5) | JP6464166B2 (ja) |
KR (1) | KR102457827B1 (ja) |
CN (2) | CN105849568B (ja) |
AU (3) | AU2014348601A1 (ja) |
BR (1) | BR112016010927A2 (ja) |
CA (1) | CA2930581A1 (ja) |
EA (1) | EA035171B1 (ja) |
IL (2) | IL245612A0 (ja) |
MX (2) | MX2016006219A (ja) |
SG (1) | SG10201803618RA (ja) |
TW (1) | TWI657827B (ja) |
WO (1) | WO2015073678A1 (ja) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE047200T2 (hu) | 2007-08-17 | 2020-04-28 | Purdue Research Foundation | PSMA kötõ ligandum-linker konjugátumok és azok alkalmazási módszerei |
US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
JP6892218B2 (ja) | 2012-11-15 | 2021-06-23 | エンドサイト・インコーポレイテッドEndocyte, Inc. | 薬物送達結合体およびpsma発現細胞によって引き起こされる疾患の治療方法 |
EP3456700A1 (en) | 2013-10-18 | 2019-03-20 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
EA037512B1 (ru) | 2015-09-30 | 2021-04-06 | Дойчес Кребсфоршунгсцентрум | Улучшенные ингибиторы простатического специфического мембранного антигена (псма), меченные 18f, и их применение в качестве визуализирующих агентов при раке простаты |
US10688200B2 (en) * | 2015-12-31 | 2020-06-23 | Five Eleven Pharma Inc. | Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy |
US10882871B2 (en) | 2016-01-10 | 2021-01-05 | British Columbia Cancer Agency Branch | 18/19F-labelled compounds which target the prostate specific membrane antigen |
EP3493855A4 (en) | 2016-08-02 | 2020-04-01 | ISI Life Sciences, Inc. | METHOD FOR DETECTION OF CANCER CELLS. |
WO2018026538A1 (en) * | 2016-08-02 | 2018-02-08 | ISI Life Sciences Inc. | Novel scaffolds for intracellular compound delivery for the detection of cancer cells |
US10239891B2 (en) | 2017-05-15 | 2019-03-26 | Indicator Systems International, Inc. | Compositions to detect remnant cancer cells |
MX2019001053A (es) | 2016-08-10 | 2019-09-23 | Cancer Targeted Tech Llc | Inhibidores de antigeno de la membrana especifico para la prostata (psma) quelados. |
WO2018098390A1 (en) * | 2016-11-23 | 2018-05-31 | Cancer Targeted Technology Llc | Albumin-binding psma inhibitors |
CN106632341A (zh) * | 2016-12-27 | 2017-05-10 | 天津阿尔塔科技有限公司 | 一种d‑叶酸的合成方法 |
US10753942B2 (en) | 2017-05-15 | 2020-08-25 | Indicator Systems International, Inc. | Methods to detect remnant cancer cells |
WO2019246445A1 (en) * | 2018-06-20 | 2019-12-26 | The Research Foundation For The State University Of New York | Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same |
CN108997170B (zh) * | 2018-08-07 | 2021-04-06 | 贾国苓 | 一种易碱解多羧基螯合物及其制备工艺 |
WO2020108753A1 (en) * | 2018-11-28 | 2020-06-04 | ITM Isotopen Technologien München AG | Novel tumor antigen binding agents and uses thereof |
EP3986872A4 (en) | 2019-06-21 | 2024-02-21 | Provincial Health Services Authority | RADIOM LABELED COMPOUNDS DIRECTED AGAINST THE PROSTATE SPECIFIC MEMBRANE ANTIGEN |
CN110627837A (zh) * | 2019-09-10 | 2019-12-31 | 齐鲁工业大学 | 一种检测一氧化碳的金属有机框架材料及制备方法和应用 |
WO2022006007A1 (en) * | 2020-06-29 | 2022-01-06 | The General Hospital Corporation | Methods for imaging bacterial infections |
JP2024511235A (ja) * | 2021-03-20 | 2024-03-12 | ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク | Mri造影剤としての混合ヒドロキシルペンダントを有する鉄(iii)大環状錯体 |
IL307499A (en) * | 2021-04-16 | 2023-12-01 | Novartis Ag | Approval of folate receptor targeted radiotherapeutic drugs and their use |
CN114028590B (zh) * | 2021-11-18 | 2022-09-06 | 北京大学 | 颗粒酶b靶向配合物、放射性药物及其制备方法和应用 |
WO2023164161A2 (en) * | 2022-02-24 | 2023-08-31 | Purdue Research Foundation | Conjugates, compositions, and methods for hydroxyapatite-targeted imaging and therapy |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795877A (en) | 1996-12-31 | 1998-08-18 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
US5672592A (en) | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
US5902817A (en) | 1997-04-09 | 1999-05-11 | Guilford Pharmaceuticals Inc. | Certain sulfoxide and sulfone derivatives |
US5863536A (en) | 1996-12-31 | 1999-01-26 | Guilford Pharmaceuticals Inc. | Phosphoramidate derivatives |
US5962521A (en) | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
US6093382A (en) * | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
AUPQ014799A0 (en) * | 1999-05-04 | 1999-05-27 | Access Pharmaceuticals Australia Pty Limited | Amplification of folate-mediated targeting to tumor cells using polymers |
US6692724B1 (en) * | 1999-10-25 | 2004-02-17 | Board Of Regents, The University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
DK1286704T3 (da) * | 2000-06-02 | 2014-09-22 | Univ Texas | Ethylendicystein (EC)-glucose analoge konjugater |
DE60231868D1 (de) | 2001-04-24 | 2009-05-20 | Purdue Research Foundation | Folat-mimetika und deren folatrezeptorbindende konjugate |
PT2260875E (pt) * | 2002-05-06 | 2014-06-25 | Endocyte Inc | Agentes de imagiologia direcionados para recetor de folato |
US7597876B2 (en) * | 2007-01-11 | 2009-10-06 | Immunomedics, Inc. | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules |
DK1592457T3 (da) | 2003-01-27 | 2012-10-22 | Endocyte Inc | Folat-vinblastin-konjugat som lægemiddel |
CN100381177C (zh) * | 2003-01-27 | 2008-04-16 | 恩多塞特公司 | 维生素受体结合递药缀合物 |
US20050085417A1 (en) * | 2003-10-16 | 2005-04-21 | Thomas Jefferson University | Compounds and methods for diagnostic imaging and therapy |
JP5149620B2 (ja) | 2004-07-23 | 2013-02-20 | エンドサイト,インコーポレイテッド | 2価リンカーおよびその結合体 |
EP1904183B1 (en) * | 2005-07-05 | 2014-10-15 | Purdue Research Foundation | Pharmaceutical composition for the treatment of osteoarthritis |
AU2006279304A1 (en) | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Multi-drug ligand conjugates |
EP1940841B9 (fr) * | 2005-10-07 | 2017-04-19 | Guerbet | Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium |
US9265746B2 (en) * | 2006-05-31 | 2016-02-23 | Merck & Cie | Method for cell-specific targeting |
US10925977B2 (en) * | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
CN101568352B (zh) * | 2007-01-11 | 2013-08-21 | 免疫医学股份有限公司 | 用于蛋白质、肽和其他分子的改进的f-18标记的方法和组合物 |
EP2567711A3 (en) * | 2007-02-07 | 2013-05-01 | Purdue Research Foundation | Positron emission tomography imaging method |
WO2008101231A2 (en) * | 2007-02-16 | 2008-08-21 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
CN104383553A (zh) | 2007-06-25 | 2015-03-04 | 恩多塞特公司 | 含有亲水性间隔区接头的共轭物 |
ES2700234T3 (es) * | 2007-06-26 | 2019-02-14 | Univ Johns Hopkins | Inhibidores marcados del antígeno de membrana específico de la próstata (PSMA), evaluación biológica y uso como agentes para la obtención de imágenes |
HUE047200T2 (hu) * | 2007-08-17 | 2020-04-28 | Purdue Research Foundation | PSMA kötõ ligandum-linker konjugátumok és azok alkalmazási módszerei |
PL2644594T3 (pl) * | 2007-09-28 | 2018-01-31 | Pfizer | Ukierunkowanie na komórki nowotworowe za pomocą nanocząstek |
WO2010019446A1 (en) * | 2008-08-09 | 2010-02-18 | University Of Iowa Research Foundation | Nucleic acid aptamers |
LT3964502T (lt) * | 2009-03-19 | 2024-08-26 | The Johns Hopkins University | Junginiai nukreipti į psma ir jų panaudojimas |
US9951324B2 (en) * | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
CA2790577A1 (en) * | 2010-02-25 | 2011-09-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
CN101863924B (zh) * | 2010-05-17 | 2012-06-27 | 北京师范大学 | 99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法 |
AU2012294639B2 (en) * | 2011-08-05 | 2017-10-26 | Molecular Insight Pharmaceuticals, Inc. | Radiolabeled prostate specific membrane antigen inhibitors |
WO2013130776A1 (en) * | 2012-02-29 | 2013-09-06 | Purdue Research Foundation | Folate receptor alpha binding ligands |
BR112015008365A2 (pt) * | 2012-10-16 | 2017-07-04 | Endocyte Inc | composto da fórmula b-l(d)x, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, composição de forma de dosagem unitária ou dose unitária, composição para tratar um câncer em um paciente, e método para tratar um câncer em um paciente |
US20160199500A1 (en) * | 2013-08-22 | 2016-07-14 | Syracuse University | Compositions comprising vitamin b12 and intrinsic factor and methods of use thereof |
CN103951668A (zh) * | 2014-04-25 | 2014-07-30 | 广州军区广州总医院 | 叶酸衍生物的正电子核素标记物及其应用 |
-
2014
- 2014-11-13 CN CN201480071256.XA patent/CN105849568B/zh active Active
- 2014-11-13 AU AU2014348601A patent/AU2014348601A1/en not_active Abandoned
- 2014-11-13 WO PCT/US2014/065467 patent/WO2015073678A1/en active Application Filing
- 2014-11-13 EA EA201690862A patent/EA035171B1/ru unknown
- 2014-11-13 EP EP14861854.9A patent/EP3069147A4/en not_active Withdrawn
- 2014-11-13 SG SG10201803618RA patent/SG10201803618RA/en unknown
- 2014-11-13 KR KR1020167015740A patent/KR102457827B1/ko active IP Right Grant
- 2014-11-13 CN CN201810300332.XA patent/CN108514646B/zh active Active
- 2014-11-13 US US15/035,936 patent/US20160287731A1/en not_active Abandoned
- 2014-11-13 MX MX2016006219A patent/MX2016006219A/es unknown
- 2014-11-13 EP EP20180928.2A patent/EP3777898A3/en active Pending
- 2014-11-13 BR BR112016010927A patent/BR112016010927A2/pt active Search and Examination
- 2014-11-13 CA CA2930581A patent/CA2930581A1/en active Pending
- 2014-11-13 JP JP2016529948A patent/JP6464166B2/ja active Active
- 2014-11-13 EP EP19167560.2A patent/EP3533473A3/en not_active Withdrawn
- 2014-11-14 TW TW103139664A patent/TWI657827B/zh active
-
2016
- 2016-05-11 IL IL245612A patent/IL245612A0/en active IP Right Grant
- 2016-05-12 MX MX2022014611A patent/MX2022014611A/es unknown
-
2018
- 2018-08-20 IL IL261259A patent/IL261259B/en active IP Right Grant
- 2018-10-10 US US16/157,024 patent/US20190275181A1/en not_active Abandoned
- 2018-11-06 JP JP2018208786A patent/JP2019023232A/ja active Pending
-
2020
- 2020-03-30 JP JP2020060644A patent/JP2020165975A/ja active Pending
-
2021
- 2021-01-07 AU AU2021200067A patent/AU2021200067B2/en active Active
- 2021-09-29 US US17/488,810 patent/US20220125958A1/en active Pending
- 2021-10-27 JP JP2021175168A patent/JP7299285B2/ja active Active
-
2023
- 2023-05-02 AU AU2023202704A patent/AU2023202704A1/en active Pending
- 2023-06-15 JP JP2023098521A patent/JP2023107988A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2023107988A5 (ja) | ||
JP2021073272A5 (ja) | ||
JP2007526496A5 (ja) | ||
JP2002542342A5 (ja) | ||
JP2013510860A5 (ja) | ||
JP2008505157A5 (ja) | ||
JP2005532287A5 (ja) | ||
JP2005504811A5 (ja) | 置換ペンタセン化合物、半導体デバイス及び物品 | |
JP2007503202A5 (ja) | ||
JP2023171659A5 (ja) | ||
CA2457054A1 (en) | Activator of peroxisome proliferator-activated receptor .delta. | |
JP2006526590A5 (ja) | ||
JP2009541288A5 (ja) | ||
JP2004537517A5 (ja) | ||
JP2009522364A5 (ja) | ||
JP2006502283A5 (ja) | ||
JP2007534479A5 (ja) | ||
JP2006520397A5 (ja) | ||
JP2004535412A5 (ja) | ||
JP2008506697A5 (ja) | ||
JP2004502755A5 (ja) | ||
JP2004523478A5 (ja) | ||
JPWO2022130990A5 (ja) | ||
JP2010518158A5 (ja) | ||
KR880011082A (ko) | β-아미노 에틸-치환된 페닐 화합물 및 그들의 약제학적으로 허용되는 염 및 아미드 |